2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(2R,3S,4S)-tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-furanyl]methyl ester, (2E)-rel-(+)- - Names and Identifiers
2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(2R,3S,4S)-tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-furanyl]methyl ester, (2E)-rel-(+)- - Physico-chemical Properties
Molecular Formula | C29H30O8
|
Molar Mass | 506.55 |
Density | 1.292±0.06 g/cm3(Predicted) |
Boling Point | 709.4±60.0 °C(Predicted) |
Appearance | Powder |
pKa | 9.69±0.26(Predicted) |
Storage Condition | 2-8℃ |
2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(2R,3S,4S)-tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-furanyl]methyl ester, (2E)-rel-(+)- - Introduction
Lariciresinol p-coumarate (chrysophanol p-cinnamate) is a natural compound belonging to the class of lignin compounds. It is synthesized from chrysophanol and p-cinnamate by esterification. Lariciresinol p-coumarate is widely present in plants and has a variety of physiological activities.
Some properties of Lariciresinol p-coumarate include: colorless or yellowish solid, with good solubility, soluble in organic solvents such as alcohols, esters and ethers, insoluble in water. It has antioxidant, anti-inflammatory, anti-cancer and antibacterial activities, and can be used in pharmaceutical, cosmetic and food industries.
The main uses of Lariciresinol p-coumarate include:
1. Drug development: Due to its antioxidant and anti-inflammatory properties, Lariciresinol p-coumarate can be used to treat cardiovascular diseases, cancer and skin problems.
2. Cosmetics: as a moisturizer, anti-aging agent and whitening agent added to a variety of cosmetics to nourish the skin and reduce wrinkles.
3. Food additives: added to food as natural antioxidants to extend food shelf life and improve nutritional value.
The preparation method of Lariciresinol p-coumarate is mainly through chemical synthesis. Rhubarb phenol and p-cinnamate can be reacted by esterification under appropriate conditions to produce Lariciresinol p-coumarate.
Regarding safety information, the current toxicity assessment of Lariciresinol p-coumarate is limited, so caution is required during use. Appropriate safety procedures and laboratory practices should be carried out before use to avoid contact with skin, eyes and respiratory organs. In addition, the safety of Lariciresinol p-coumarate may need to be further evaluated depending on the environment and dose of use. If necessary, it is recommended to consult a toxicologist or relevant agency for more detailed and accurate safety information.
Last Update:2024-04-09 20:49:11